Brief: Octagon Capital Advisors Reports 10.1% Passive Stake In AN2 Therapeutics As Of June 13
03/07/2024 13:11
July 3 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* OCTAGON CAPITAL ADVISORS LP REPORTS 10.1% PASSIVE STAKE IN
AN2
THERAPEUTICS AS OF JUNE 13 - SEC FILING
Source text for Eikon: ID:n0001214659-24-011905
Further company coverage: ANTX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview